What Does Bicara Therapeutics CEO Sale Signal Investors
When a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
This analysis highlights how long-term returns vary across index funds, emphasizing the impact on portfolio resilience.
28,357 articlesWhen a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
Jupiter, the Solana-based decentralized exchange, expands into tokenized IP by listing onchain Pokémon cards. The mov...
Sweetgreen faces a turning point after a tough year. This article examines if a 'wraps' strategy—bundled menu changes...
Intel posted a stronger-than-expected Q1, yet rising costs and cash-flow strain raise the risk of a sharper pullback....
Insider trades can reveal more than cash changing hands. Explore how a recent Warby Parker director sold shares, what...
Rising electricity costs driven by AI data centers are reshaping the landscape for utility stocks. This deep dive exp...
A Murphy USA senior executive recently sold shares in an open-market move valued at roughly $344,000. This article br...
A speculative bid by GameStop to purchase eBay sparks fresh debate about stock-based deals and the risk of overpaying...
Sequoia Capital partner Sean Maguire argues SpaceX sits at a pivotal point similar to Nvidia’s breakout years, and he...
Dell shares tumbled about 14% as investors pulled back from AI hardware names, with HPE and Super Micro also sliding....
Sea Ltd reports a sharp rise in 2025 earnings driven by fintech growth and new markets, but worries over profitabilit...
Bitcoin jumped to an intraday high near $82,000 on Thursday after a Senate committee advanced the Clarity Act, then e...